Publication: 250

Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the Cancer and Leukemia Group B (CALGB 9281).
      Google Scholar   
Citation:
J Clin Oncol vol 26 (19) 3229-34
Year:
2008
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
797  
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
CA33601, CA32291, CA03927, CA35421, CA04326, CA47559, CA31946  
Corr. Author:
 
Authors:
                         
Networks:
 
Study
CALGB-9281
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Anus Neoplasms, Carcinoma, Squamous Cell, Chemotherapy, Adjuvant, Cisplatin, Combined Modality Therapy, Female, Fluorouracil, Humans, Male, Middle Aged, Mitomycin, Neoadjuvant Therapy, Prognosis, Prospective Studies, Survival Rate, Treatment Outcome